Brokerages Set Markel Group Inc. (NYSE:MKL) Target Price at $2,025.00

Shares of Markel Group Inc. (NYSE:MKL) have received a consensus recommendation of “Hold” from the six analysts that are covering the firm, Marketbeat reports. Five research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $2,025.00.

A number of brokerages have issued reports on MKL. Wall Street Zen downgraded Markel Group from a “buy” rating to a “sell” rating in a research note on Saturday, May 2nd. Zacks Research downgraded Markel Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, January 19th. Brean Capital began coverage on Markel Group in a research note on Tuesday, March 24th. They issued a “neutral” rating and a $2,100.00 price objective for the company. Truist Financial reduced their price objective on Markel Group from $2,100.00 to $1,950.00 and set a “hold” rating for the company in a research note on Thursday, April 30th. Finally, Weiss Ratings downgraded Markel Group from a “buy (b)” rating to a “hold (c+)” rating in a research note on Wednesday, April 29th.

Markel Group Trading Up 0.7%

Shares of MKL stock opened at $1,798.24 on Friday. Markel Group has a 52-week low of $1,719.41 and a 52-week high of $2,207.59. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.63 and a current ratio of 0.63. The company has a 50-day simple moving average of $1,931.50 and a two-hundred day simple moving average of $2,017.25. The company has a market capitalization of $22.50 billion, a price-to-earnings ratio of 12.96 and a beta of 0.67.

Markel Group (NYSE:MKL) last issued its quarterly earnings data on Tuesday, April 28th. The insurance provider reported ($18.90) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $26.38 by ($45.28). Markel Group had a return on equity of 7.90% and a net margin of 10.85%.The firm had revenue of $2.82 billion during the quarter, compared to the consensus estimate of $3.66 billion. Research analysts anticipate that Markel Group will post 113.77 EPS for the current fiscal year.

Insider Buying and Selling at Markel Group

In other news, CEO Simon Wilson sold 100 shares of the stock in a transaction that occurred on Thursday, February 26th. The shares were sold at an average price of $2,079.48, for a total transaction of $207,948.00. Following the completion of the transaction, the chief executive officer directly owned 2,397 shares of the company’s stock, valued at $4,984,513.56. This represents a 4.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.08% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of MKL. Brighton Jones LLC bought a new position in shares of Markel Group during the 4th quarter valued at approximately $236,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Markel Group by 13.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 109 shares of the insurance provider’s stock worth $204,000 after acquiring an additional 13 shares during the period. Goldman Sachs Group Inc. grew its stake in shares of Markel Group by 9.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 34,704 shares of the insurance provider’s stock worth $64,883,000 after acquiring an additional 3,083 shares during the period. Empowered Funds LLC grew its stake in shares of Markel Group by 49.1% during the 1st quarter. Empowered Funds LLC now owns 416 shares of the insurance provider’s stock worth $778,000 after acquiring an additional 137 shares during the period. Finally, Arrowstreet Capital Limited Partnership bought a new position in shares of Markel Group during the 2nd quarter worth $463,000. 77.12% of the stock is owned by institutional investors.

Markel Group Company Profile

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.